Eribulina Eg

Eribulin is a chemotherapy medication used to treat certain types of cancer. It works by slowing or stopping cancer cell growth, often prescribed for advanced breast cancer and liposarcoma.

Eribulin is primarily used in the treatment of metastatic breast cancer and liposarcoma. It is a chemotherapy agent that targets rapidly dividing cancer cells, helping to slow or stop their growth. Patients often wonder, 'What is Eribulin used for?' It is typically administered intravenously and is part of a broader cancer treatment plan.

Common effects of Eribulin may include fatigue, nausea, and hair loss. Some patients also experience peripheral neuropathy, which can cause tingling or numbness in the hands and feet. These effects vary among individuals and should be discussed with a healthcare provider.

Eribulin should be handled with care, as it is a potent chemotherapy agent. It is important to follow proper safety protocols when administering the medication. Patients should be monitored for signs of infection or other complications, and any concerns should be reported to a healthcare professional.

Eribulin may interact with other medications, including those that affect liver enzymes. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Eribulin.